Core Viewpoint - Guangzhou Pharmaceutical, a subsidiary of Baiyunshan, has successfully acquired 100% equity of Zhejiang Pharmaceutical Industry Co., Ltd. from Haizheng Pharmaceutical for 500 million yuan, marking a strategic move to enhance its market presence in East China [1][2]. Group 1: Acquisition Details - The acquisition process began with a public transfer, where Guangzhou Pharmaceutical won the bid at a price of 500 million yuan on December 10, 2023, and paid a deposit of 86 million yuan [1]. - Zhejiang Pharmaceutical is a leading pharmaceutical distribution company in Zhejiang, with a distribution network covering over 99% of public hospitals in the province [1]. Group 2: Strategic Importance - This acquisition is seen as a significant step for Guangzhou Pharmaceutical to strengthen its presence in the East China market, which is crucial for pharmaceutical distribution due to its high population density and strong medical consumption capacity [2]. - The deal is expected to create synergies between Guangzhou Pharmaceutical and Zhejiang Pharmaceutical, enhancing resource sharing, business collaboration, and channel integration [3]. Group 3: Future Prospects - Post-acquisition, Guangzhou Pharmaceutical aims to leverage Zhejiang Pharmaceutical's established distribution network to accelerate the implementation of innovative business models such as SPD and pharmaceutical e-commerce in the Yangtze River Delta region [3]. - The acquisition aligns with Baiyunshan's broader strategy of capital operations, which includes recent acquisitions in various sectors such as traditional Chinese medicine and diagnostics, showcasing a clear trend of upstream and downstream integration [4].

公司未来将持续围绕硬质合金领域进行深度挖掘，坚持以市场为导向，在巩固当前 市场优势地位的基础上，朝着细分行业龙头企业的目标发展，开拓精度高、稳定性强和 技术含量高的硬质合金产品，打造产业链上下游一体化的可持续发展生态版图。此次成 功挂牌是其发展历程中的重要节点，肯特合金将以此为契机，聚焦主业，借助资本市场 的力量持续发展壮大。 作为肯特合金本次推荐挂牌的主办券商，申万宏源承销保荐从前期筹划到落地执 行，为肯特合金提供了专业且细致的全流程服务支持。项目团队充分发挥专业优势，挖 掘肯特合金的技术亮点和企业价值，高效对接监管机构，协助其顺利完成挂牌。未来， 申万宏源承销保荐将继续为肯特合金提供全方位、综合性的金融服务，助力其在行业中 持续领航，共同为实体经济的繁荣贡献力量。 来源：申万宏源承销保荐 2025年4月16日，株洲肯特硬质合金股份有限公司（证券简称："肯特合金"，股票 代码：874696）成功在全国中小企业股份转让系统挂牌。申万宏源承销保荐担任本次 挂牌主办券商，凭借专业、细致、高效的服务，助力客户成功登陆资本市场。 免责声明 肯特合金成立于2006年，专业从事硬质合金制品的研发、生产及销售，主要产品 包 ...